KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得

Assessing Polypoidal Choroidal Vasculopathy-Related OCT Features in the TENAYA and LUCERNE Trials.

Kelvin Yi Chong Teo, Philippe Margaron, Timothy Y Y Lai, Won Ki Lee, Srinivas R Sadda, Giovanni Staurenghi, Shriji Patel, Chui Ming Gemmy Cheung

Ophthalmol Sci 6(7) 101217

PMID42383222
PMCIDPMC13316682
DOI10.1016/j.xops.2026.101217
发表日期2026-07-01
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 4 张 PubMed Figure,均未识别为 KM 图:Figure 1:图注未提示 KM 曲线;Figure 2:CONSORT/入组流程图;Figure 3:图注未提示 KM 曲线;Figure 4:图注未提示 KM 曲线。
摘要

摘要

OBJECTIVE: To describe OCT features associated with polypoidal choroidal vasculopathy (PCV) in the TENAYA and LUCERNE clinical trial cohorts. DESIGN: Imaging analysis within 2 multinational, double-masked, randomized controlled phase III trials. SUBJECTS: Participants with treatment-naïve neovascular age-related macular degeneration enrolled in TENAYA and LUCERNE with baseline OCT and in a subset, baseline indocyanine green angiography (ICGA). METHODS: Previously described OCT features associated with PCV were evaluated among 1329 participants. Two major OCT features were evaluated (sharp-peaked pigment epithelial detachment [SPED] and sub-retinal pigment epithelium ring-like lesion) to determine the occurrence of OCT-defined PCV. Subretinal fluid, intraretinal fluid (IRF), and hyperreflective material (HRM), were compared between OCT-defined PCV and non-PCV eyes. A sensitivity analysis was performed in the subset of eyes with available ICGA to assess concordance between OCT and ICGA-confirmed PCV. MAIN OUTCOME MEASURES: Occurrence of OCT-defined PCV and distribution of OCT-based disease activity biomarkers by PCV status. RESULTS: Using the 2 major OCT criteria, 88 (6.7%) of eyes were classified as OCT-defined PCV. Fewer OCT-defined PCV eyes had IRF and HRM compared with non-PCV eyes (27.3% vs. 45.5%, P = 0.002, 19.3% vs. 47.0%, P < 0.001). In the ICGA subset (n = 274), the combination of SPED and ring demonstrated good sensitivity (85.2%) and high specificity (98.8%) relative to ICGA. CONCLUSIONS: Using 2 Asia-Pacific Ocular Imaging Society major OCT features, OCT-based diagnostic strategy may help triage or screen for PCV when ICGA is unavailable. FINANCIAL DISCLOSURES: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(4,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Figure 1Figure 1 Representative multimodal imaging features used for the diagnosis of polypoidal lesions on non-ICGA imaging. Left column (top and bottom images) demonstrates polypoidal choroidal vasculopathy identified on ICGA, corresponding OCT B-scan (center column, top and bottom images), and enlarged OCT image (right column, top and bottom images). The enlarged OCT images show a sharply peaked pigment epithelial detachment outlined in white. The dashed oval outlines the ring like lesion that is suggestive of the polypoidal lesion. The double layer sign is identified between the white arrow heads. These imaging biomarkers were used as diagnostic criteria for polypoidal choroidal vasculopathy in the absence of ICGA. ICGA = indocyanine green angiography.
非 KM Figure
Figure 2Figure 2 Study flow diagram and derivation of the OCT-defined PCV cohort. Flowchart showing participant inclusion, image gradability, and identification of eyes with OCT-defined polypoidal choroidal vasculopathy (PCV). Among 1329 eyes enrolled, 1317 had gradable OCT imaging. A subset of 275 eyes had both ICGA and gradable OCT available for sensitivity analysis, of which 274 were gradable on both modalities. Within the ICGA subset, 26 eyes met OCT criteria for PCV (sharp-peaked pigment epithelial detachment [SPED] and ring sign), including 23 true positives, 3 false positives, and 4 false negatives relative to ICGA. ICGA = indocyanine green angiography.
非 KM Figure
Figure 3Figure 3 Major and minor OCT features identified in eyes with OCT-defined PCV. Representative OCT images illustrating the major and other minor OCT features used to define PCV. The right column shows magnified views of the corresponding lesions in the left column. Top row: SPED (solid white outline), ring sign (dotted circle), and adjacent DLS (arrowheads). Middle row: SPED with associated ring sign. Bottom row: notched pigment epithelial detachment (arrow) with associated ring sign. DLS = double-layer sign; PCV = polypoidal choroidal vasculopathy; SPED = sharp-peaked pigment epithelial detachment.
非 KM Figure
Figure 4Figure 4 Representative examples of the OCT ring sign in ICGA-confirmed PCV. Mid-phase ICGA images (left) and corresponding OCT B-scans (right) from eyes with ICGA-confirmed polypoidal choroidal vasculopathy. The OCT ring sign appears as a hyperreflective ring surrounding a hyporeflective lumen within a pigment epithelial detachment and corresponds spatially to the polypoidal lesions identified on ICGA. Dashed lines indicate the OCT scan location. These examples demonstrate the characteristic OCT appearance underlying the high sensitivity of the ring sign for identifying PCV, including in the absence of a concomitant sharp-peaked pigment epithelial detachment (SPED), which frequently accompanies the ring sign. ICGA = indocyanine green angiography; PCV = polypoidal choroidal vasculopathy.
非 KM Figure